Enbridge Energy, Limited Partnership (NYSE:EEP) had its target price lowered by Barclays from $16.00 to $11.00 in a research report sent to investors on Tuesday morning, Marketbeat reports. The brokerage currently has an equal weight rating on the pipeline company’s stock.
When Warren Buffett announced in 2006 that he would graduallygive away the majority of his fortune to charity,he wasnt kidding.
The billionaire investor just donated another 18.6 million Class B shares of Berkshire Hathaway worth $3.17 billion to five different foundations. That puts his total charitable contribution to the organizations at $27.54 billion in just over ten years.
Valeant Pharmaceuticals (NYSE:VRX) shares are on a tear, and the company’s first-quarter financial results show that management is making headway in paying down debt. However, the business itself continues to sputter, and ultimately this rally could be short-lived if sales can’t find their footing.
The good news
Valeanthas been struggling to offset declining sales following....More>>>
The market has seen a strong December thus far, but few stocks can hold a candle to Nokia (NYSE:NOK). Nokia is up over 13% thus far in December, and up more than 20% off its November lows. For Nokia investors, this year-end rally has been a welcome surprise after an abysmal year. While the S&P-500 (NYSEARCA:SPY) is up 10% for the year, Nokia is down over 30%. Unfortunately for Nokia bears, ugly....More>>>
A new and highly anticipated study byCelgene Corp. (NASDAQ:CELG) shows that its promising multiple sclerosis drug could soon reshape the $19 billion multiple sclerosis market. On Friday, management reported that ozanimod met its primary endpoint for reducing MS relapses better than Biogen Inc.’s (NASDAQ:BIIB) Avonex, and importantly, it did so without any new safety risks.
ContraVir Pharmaceuticals Inc. (NASDAQ: CTRV) is watching its shares climb on Thursday after the company reported positive interim data from its ongoing Hepatitis B (HBV) mid-stage trial. Specifically, the company announced data for CMX157, its highly potent prodrug of tenofovir.
Overall the study is the first evaluation of CMX157 in HBV patients, and directly compares CMX157 to tenofovir....More>>>
Every day Florida's population swells by more than 1,000 people, many of them retirees relocating for the second halves of their lives. There's little mystery why: Even in the coldest months of the year, the average daily high is at least 70 degrees, and the temperature rarely dips below 50 in th
A few weeks ago, Allergan (NYSE:AGN) announced a tender offer to refinance a portion of its outstanding debt. Today, Allergan announced the results of that tender offer and also announced the pricing of the offering to refinance the debt, which gave us some of the necessary figures to calculate t
Drive Shack (NYSE:DS) shares have been under pressure since the company's December announcement of its business transformation (see press release, conference call, and investor presentation). Key points:
The markets managed to hold onto weekly gains on Friday despite a weaker-than-anticipated gross domestic product (GDP) figure. The U.S. economy slowed a bit during the fourth quarter with a seasonally adjusted annual rate of 1.9%, the Commerce Department
My Top Pick for income investors is a firm that is situated nicely to take advantage of the market's hard pivot toward industrial stocks — a trend that should continue in 2017, explains Chuck Carlson, a specialist in dividend reinvestment plans and editor of DRIP Investor.